Volume 76, Issue 6 pp. 499-503
Original Article

An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens

Fabiana Cro'

Fabiana Cro'

Geneticlab, Noventa Vicentina, Italy

Search for more papers by this author
Cristina Lapucci

Cristina Lapucci

Geneticlab, Noventa Vicentina, Italy

Search for more papers by this author
Emilio Vicari

Emilio Vicari

Geneticlab, Noventa Vicentina, Italy

Search for more papers by this author
Ginevra Salsi

Ginevra Salsi

Division of Prenatal Medicine, Department of Medicine and Surgery (DIMEC), University of Bologna, Bologna, Italy

Search for more papers by this author
Nicola Rizzo

Nicola Rizzo

Division of Prenatal Medicine, Department of Medicine and Surgery (DIMEC), University of Bologna, Bologna, Italy

Search for more papers by this author
Antonio Farina

Corresponding Author

Antonio Farina

Division of Prenatal Medicine, Department of Medicine and Surgery (DIMEC), University of Bologna, Bologna, Italy

Correspondence

Antonio Farina, Division of Obstetrics and Gynecology, Department of Medicine and Surgery (DIMEC), University of Bologna, Bologna, Italy.

Email: [email protected]

Search for more papers by this author
First published: 11 October 2016
Citations: 5

Funding information:

RFO (University of Bologna, Italy) to Antonio Farina.

Abstract

Objective

The aim of this study was to present a new method for fetal Kell genotyping by means of the allelic discrimination of K1 and K2 in real-time polymerase chain reaction (PCR).

Methods

Real-time quantitative polymerase chain reaction incorporating an allele-specific primer was developed for detecting the K allele of KEL.

Results

By means of this method, the K1/K2 genotype was able to be determined in all blood samples analyzed. Results using cell-free fetal DNA (cffDNA) from two Kell-negative pregnant women confirmed the Kell-positive genotype of fetuses. The real-time PCR analysis also allowed the determination of the fetal fraction using the quantification of Kell-positive DNA.

Conclusion

An efficient and reliable strategy for Kell genotyping is herein presented. The method was optimized on cffDNA to create a non-invasive prenatal test which could be routinely used for the prevention of hemolytic disease of the fetus and the newborn (HDFN).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.